| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/22/2004 | CN1180805C Medicine for curing burn and scald and its production method |
| 12/22/2004 | CN1180773C Transdermal drug delivery system for anti-inflammatory analogesic agent comprising diclofenac diethylammonium and the manufacturing method thereof |
| 12/22/2004 | CN1180771C Oral cavity adhesive plaster composition for curing gingival disease, laryngopharyngitis and halitosis |
| 12/22/2004 | CN1180769C Polymer based rapidly dissolving tablets and production processes thereof |
| 12/21/2004 | US6833478 N,N-dinitramide salts as solubilizing agents for biologically active agents |
| 12/21/2004 | US6833439 IP-10/MIG receptor designated CXCR3, nucleic acids and methods of use therefor |
| 12/21/2004 | US6833406 Liquid dispersion polymer compositions, their preparation and their use |
| 12/21/2004 | US6833140 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity |
| 12/21/2004 | CA2160762C Medicated and/or nutritional microcapsules for oral delivery |
| 12/16/2004 | WO2004109840A1 Electrode, method of forming the same, photoelectric conversion device, process for producing the same, electronic apparatus and process for producing the same |
| 12/16/2004 | WO2004109390A1 Laser projector |
| 12/16/2004 | WO2004108923A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 12/16/2004 | WO2004108796A1 Polyamino acids functionalised with at least one hydrophobic group and applications thereof particularly therapeutic applications |
| 12/16/2004 | WO2004108747A2 Lectin conjugates |
| 12/16/2004 | WO2004108634A2 Reagents for modifying biopharmaceuticals, the use and production thereof |
| 12/16/2004 | WO2004108165A2 Magnetic nanoparticles linked to a lingand |
| 12/16/2004 | WO2004108152A1 Stable, aqueous solution of human erythropoietin, not containing serum albumin |
| 12/16/2004 | WO2004108118A1 Stabilized aerosol dispersions |
| 12/16/2004 | WO2004108116A2 Stabilized particle dispersions containing surface-modified inorganic nanoparticles |
| 12/16/2004 | WO2004108115A1 Process for producing microparticle |
| 12/16/2004 | WO2004108113A1 Improved novel, clear, painless preparation of propofol |
| 12/16/2004 | WO2004108072A2 Delivery of immune response modifier compounds using metal-containing particulate support materials |
| 12/16/2004 | WO2004108071A2 Targeting polypeptides to the central nervous system |
| 12/16/2004 | WO2004108070A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 12/16/2004 | WO2004094991A3 Treatment or prevention of respiratory viral infections with alpha thymosin peptides |
| 12/16/2004 | WO2004091541A3 Methods for the controlled delivery of pharmacologically active compounds |
| 12/16/2004 | WO2004087043A3 Stable ophthalmic formulation containing an antibiotic and a corticosteroid |
| 12/16/2004 | WO2004082594A3 Alginate sponge and preparation method thereof |
| 12/16/2004 | WO2004082590A3 A low dose corticosteroid composition |
| 12/16/2004 | WO2004071545A3 Compositions for neuronal tissue regeneration |
| 12/16/2004 | WO2004062602A3 Compositions and methods for targeted biological delivery of molecular carriers |
| 12/16/2004 | WO2004046202A3 Bio-degradable colloid particles, in particular for pulmonary applications |
| 12/16/2004 | WO2004032963A3 Photokinetic delivery of biologically active substances using pulsed incoherent light |
| 12/16/2004 | WO2003105908B1 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 12/16/2004 | WO2003090684A8 Polymer compositions containing a macrocyclic triene compound |
| 12/16/2004 | WO2003035011A8 Multidrug multiligand conjugates for targeted drug delivery |
| 12/16/2004 | US20040255336 Methods and apparatus for simultaneous program viewing |
| 12/16/2004 | US20040254618 Implantable device and method for the electrical treatment of cancer |
| 12/16/2004 | US20040254495 Standardized swallow challenge medium and method of use for esophageal function testing |
| 12/16/2004 | US20040254352 Comprising active agent and lipid-polymer conjugate, obtainable from an amphiphilic lipid, consisting of at least one hydrophobic apolar moiety and a hydrophylic polar head group, and a polymer or monomeric precursor therefor, the polymer being a poly(amino acid) or a poly(amino acid) derivative |
| 12/16/2004 | US20040254344 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 12/16/2004 | US20040254252 Tpoical applying a mixture containing alkoxybenzaldehyde compound |
| 12/16/2004 | US20040254243 Drink preparation comprising ketoprofen and its use in the simultaneous treatment of conditions causing fever, inflammation and pain in a herd of animals |
| 12/16/2004 | US20040254210 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 12/16/2004 | US20040254202 Method of promoting sleep using topical administration of vasoactive agents |
| 12/16/2004 | US20040254197 Injections for eye tissues containing drug bonded to polyethlene glycol |
| 12/16/2004 | US20040254165 Vitiligo; skin cancer; control skin coloring |
| 12/16/2004 | US20040254149 Antiproliferative agents; antiinflammatory agents; anticancer agents; diagnosis, therapy |
| 12/16/2004 | US20040254146 Carboxylate salts of galantamine and their pharmaceutical use |
| 12/16/2004 | US20040254129 In aqueous solution;prevent cell damage; mixture with drug or nitritional supplment |
| 12/16/2004 | US20040254128 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 12/16/2004 | US20040254119 Polypeptide conjugates with extended circulating half-lives |
| 12/16/2004 | US20040254108 Preparation and application of anti-tumor bifunctional fusion proteins |
| 12/16/2004 | US20040254096 Mucin synthesis inhibitors |
| 12/16/2004 | US20040254087 Core of active material with wax coating |
| 12/16/2004 | US20040253731 Solution comprising surfactant, hydrophobic phase and hydrophilic phase comprising plurality of microcapsules containing functional in vitro eukaryotic expression system for transfer of heterologous into cells |
| 12/16/2004 | US20040253690 Process for producing isomaltose and use thereof |
| 12/16/2004 | US20040253601 Methods for overexpression of high molecular weight form of mannose binding lectin (MBL) and a specific formulation for active treatment for systemic infection with microorganism |
| 12/16/2004 | US20040253587 Antagonists of interleukin-15 |
| 12/16/2004 | US20040253578 Solid support comprising immobilized dynamic action reference tools (DART)/bioconjugates for use in isolation and analysis of nucleic acids and polypeptides; drug screening |
| 12/16/2004 | US20040253318 Preventing, alleviating symptoms of a skin condition with a complexes, such as lauryliminodipropionic acid tocopheryl phosphate; penetrating and absorption into skin; inflammation, erythema, wound, burn, dermatitis, gingivitis, sunburn, heat burn, psoriasis; cosmetics |
| 12/16/2004 | US20040253317 Pharmaceutical preparation for the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma |
| 12/16/2004 | US20040253316 Production scale method of forming microparticles |
| 12/16/2004 | US20040253314 Melt extrusion of salts of active ingredients |
| 12/16/2004 | US20040253300 Medication and method for remediating existing scars through transdermal, topical delivery of calcium channel blockers |
| 12/16/2004 | US20040253294 A crosslinked, acidic, high molecular weight gelatin hydrogel obtained from alkali hydrolyzed collagen, impregnated with hepatocyte growth factor, and having an isoelectric point of 5 and a zeta potential between -15 and -20 mV; angiogenesis promoters; arterial diseases |
| 12/16/2004 | US20040253281 Inks include surface activated immobilized drug, controlled release agent, and have the ability to differentiate active ingredients by location and dosage; tatoos; vapor deposition; gene therapy |
| 12/16/2004 | US20040253280 Ophthalmic compositions containing a synergistic combination of two polymers |
| 12/16/2004 | US20040253277 Anaesthetic formulations of propofol |
| 12/16/2004 | US20040253276 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization |
| 12/16/2004 | US20040253275 Pharmaceutical and cosmetic carrier or composition for topical application |
| 12/16/2004 | US20040253248 Substance P-saporin (SP-SAP) conjugates and methods of use thereof |
| 12/16/2004 | US20040253247 Conjugate comprising a peptide having an engineered amino acid sequence capable of binding a plasma protein, said peptide conjugated to the therapeutic or diagnostic substance, wherein elimination half time of conjugate exceeds that of unconjugated therapeutic or diagnostic substance; peptide ligands |
| 12/16/2004 | US20040253206 etoposide; hydrophobic drug attached to amphiphilic ethylene glycol oligomer or polymer via hydrolyzable bond; improves ability to penetrate blood-brain barrier; bond hydrolyzes in vivo, freeing the fully bioactive drug; improves solubility of the drug in the bloodstream; drug delivery to CNS |
| 12/16/2004 | US20040253192 Pullulan free edible film composition comprising a film forming agent and an antimicrobial agent which is cardamom oil; chewing gums, confections, mouthwashes, mouth sprays and edible thin films |
| 12/16/2004 | US20040253191 Breath Freshening and Oral Cleansing Product |
| 12/16/2004 | US20040253185 Medicated ink |
| 12/16/2004 | DE202004015623U1 Lubricant, for use during sexual intercourse, incorporates a sexual stimulant which can also be used in a soap to give an arousal effect when washing |
| 12/16/2004 | DE10324710A1 Stärkederivatkomplexe Starch derivative complexes |
| 12/16/2004 | DE10323279A1 Gebrauchsfertige Gemcitabin-Lösungen Ready gemcitabine solutions |
| 12/16/2004 | DE10323278A1 Gebrauchsfertige Gemcitabin-Lösungskonzentrate Ready gemcitabine solution concentrates |
| 12/16/2004 | DE10058384B4 Kosmetisches oder dermatologisches Mittel in Form eines cremigen Permanentschaums oder einer stabil aufgeschäumten Creme, deren Verwendung und Verfahren zur Herstellung des Mittels Cosmetic or dermatological composition in the form of a foam or creamy permanent stable foamed cream, their use and process for the preparation of the agent |
| 12/16/2004 | CA2528136A1 Transfection agents |
| 12/16/2004 | CA2527994A1 Process for producing microparticles |
| 12/16/2004 | CA2527988A1 Cosmetic patch and using method thereof, and cosmetic patch package |
| 12/16/2004 | CA2527984A1 Vascular endothelial growth factor fusion constructs and uses thereof |
| 12/16/2004 | CA2527926A1 Controlled release formulations |
| 12/16/2004 | CA2527658A1 Methods and compositions for interferon therapy |
| 12/16/2004 | CA2526435A1 Polyamino acids functionalised with at least one hydrophobic group and applications thereof particularly therapeutic applications |
| 12/16/2004 | CA2526007A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 12/16/2004 | CA2521682A1 Delivery of immune response modifier compounds using metal-containing particulate support materials |
| 12/15/2004 | EP1486505A1 Angiotensin derivatives |
| 12/15/2004 | EP1486203A2 Surfactant compounds and uses thereof |
| 12/15/2004 | EP1485500A2 Efficient synthesis of protein-oligonucleotide conjugates |
| 12/15/2004 | EP1485421A1 Glucosamine-polyacrylate inter-polymer complex and applications thereof |
| 12/15/2004 | EP1485415A2 Neoplasm specific antibodies and uses thereof |
| 12/15/2004 | EP1485388A2 Topiramate salts and compositions comprising and methods of making and using the same |
| 12/15/2004 | EP1485349A1 Formulations of anthraquinone derivatives |
| 12/15/2004 | EP1485196A1 Vesicles comprising an amphiphilic di-block copolymer and a hydrophobic compound. |
| 12/15/2004 | EP1485145A1 Multiple compartment bag assembly for dialysis fluid |